384 First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial
2020 ◽
Vol 140
(7)
◽
pp. S37
◽
1992 ◽
Vol 98
(2)
◽
pp. 191-197
◽